In Asia Pacific, countries like China, Japan, and South Korea are witnessing rapid growth in the genotyping market. China, in particular, has emerged as a key player in the market, driven by government investments in genomics research and a growing focus on precision medicine. Japan and South Korea also have strong genotyping markets, with a focus on personalized healthcare and genetic testing.
In Europe, countries such as the United Kingdom, Germany, and France are leading the way in genotyping technologies. The UK has a robust genomics industry, with investments in large-scale genotyping projects and genomic data analysis. Germany is known for its strong biotechnology sector, driving advancements in genotyping techniques. France is also a significant player in the European genotyping market, with a focus on genetic research and genomic medicine.